Mason Graphite (MGPHF) 0.6538 $MGPHF Mason Graphite

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mason Graphite (MGPHF) 0.6538 $MGPHF

Mason Graphite Announces Continuance to CBCA
Marketwired - Fri Mar 04, 4:01PM CST
Mason Graphite Inc. ("Mason Graphite" or the "Company" (TSX VENTURE: LLG)(OTCQX: MGPHF) is pleased to announce that the Company has continued (the "Continuance" out of the jurisdiction of the Business Corporations Act (Ontario) and into the jurisdiction of the Canada Business Corporations Act (the "CBCA", effective as of March 3rd, 2016. The Continuance was approved by the shareholders of the Company at the annual and special meeting of shareholders held on December 15, 2015.
LLG.VN: 0.830 (+0.030)

Dundee Capital Markets' David Talbot Interviewed by The Energy Report
Marketwired - Thu Jan 07, 8:02AM CST
David Talbot of Dundee Capital Markets forecasts uranium demand growth of about 6% compounded annually through 2020, which ought to be more than enough to kickstart depressed U3O8 prices. Nuclear energy is part of a growing trend away from fossil fuels toward green energy and things like lithium-ion batteries for cars and energy storage. Talbot explains that lithium demand is expected to grow even faster than uranium demand, and the market is already undergoing a supply deficit. In this interview with The Energy Report, he offers his top picks in the uranium and lithium spaces, as well as a graphite name, all poised to ride the green energy trend higher.
LLG.VN: 0.830 (+0.030), FCU.TO: 0.71 (unch), UEX.TO: 0.23 (unch), NMX.VN: 1.200 (-0.040), FCU.TO: 0.71 (unch)

Mason Graphite Files the Resources Update and Feasibility Study Technical Report for Its Lac Gueret Project
Marketwired - Mon Nov 09, 6:49PM CST
Mason Graphite Inc. ("Mason Graphite" or the "Company" (TSX VENTURE: LLG)(OTCQX: MGPHF) reports that it has completed and filed the technical report entitled "NI 43-101Technical Report: Resources Update and Feasibility Study, Lac Gueret Graphite Project, Quebec, Canada" which has been prepared pursuant to Canadian Securities Administrators' National Instrument 43-101 in support of the September 25th, 2015 news release which detailed the results of a Feasibility Study for the company's Lac Gueret Project in northeastern Quebec.
LLG.VN: 0.830 (+0.030)

Mason Graphite Announces Filing of the Lac Gueret Environmental Impact Study
Marketwired - Tue Nov 03, 4:02PM CST
Mason Graphite Inc. ("Mason Graphite" or the "Company" (TSX VENTURE: LLG)(OTCQX: MGPHF) is pleased to announce the completion and filing, with the Ministere du Developpement durable, de l'Environnement et de la Lutte contre les changements climatiques (MDDELCC), of an Environmental Impact Study for its Lac Gueret Project located in northeastern Quebec.
LLG.VN: 0.830 (+0.030)

Mason Graphite Announces Feasibility Study Results Demonstrating $ 600 M NPV and 44% IRR for Its Lac Gueret Project
Marketwired - Fri Sep 25, 6:28AM CDT
Mason Graphite Inc. ("Mason Graphite" or the "Company" (TSX VENTUTRE: LLG)(OTCQX: MGPHF) reports the results of a Feasibility Study for the development of its Lac Gueret graphite project located in northeastern Quebec, Canada.

Mason Graphite Announces That the Jean-Noel-Tessier Industrial Park in Baie-Comeau Has Been Selected as the Site for its Proposed Graphite Processing Plant
Marketwired - Thu Jun 18, 8:09AM CDT
Mason Graphite Inc. ("Mason Graphite" or "the Company" (TSX VENTURE: LLG)(OTCQX: MGPHF), is pleased to announce that it has selected the site for its proposed graphite processing plant, thus achieving an important milestone in the development of its Lac Gueret graphite project located 300 kilometres north of Baie-Comeau, Quebec. The land acquisition is subject to various conditions including, among others, obtaining the requisite approvals and permits and the construction financing.
LLG.VN: 0.830 (+0.030)

Mason Graphite Inc.: Interest Payment on Convertible Debentures
Marketwired - Fri Jun 12, 5:19PM CDT
Mason Graphite Inc. ("Mason Graphite" or the "Company" (TSX VENTURE: LLG) (OTCQX: MGPHF) announces that it intends to issue an aggregate of 234,906 common shares of the Company (the "Common Shares" at a deemed price per share of $ 0.53 in payment of $ 124,500 in interest due and payable under the Company's 12% convertible debentures due June 11, 2019 (the "Debentures". Under the terms of the Debentures, the Company has the option to pay 50% of the semi-annual interest due on the Debentures in Common Shares. The balance of the interest owing under the Debentures, being $ 124,500, has been paid in cash.
LLG.VN: 0.830 (+0.030)

Mason Graphite Announces Partnership With Manicouagan-Uapishka Biosphere Reserve on the Sustainable Development and Social Acceptability of the Lac Gueret Project
Marketwired - Wed Jun 03, 8:54AM CDT
Mason Graphite Inc. ("Mason Graphite" or the "Company" (TSX VENTURE: LLG)(OTCQX: MGPHF) is pleased to announce a partnership with the Manicouagan-Uapishka Biosphere Reserve ("RMBMU" in respect of the development of the Company's Lac Gueret project. Mason Graphite will leverage the expertise of the Reference Center in sustainable development of the RMBMU in all aspects of community relations. The Company is advancing the development of a graphite deposit located 300 km North of Baie-Comeau and establishing the related processing plant in the Baie-Comeau region.
LLG.VN: 0.830 (+0.030)

Mason Graphite Concludes Agreements With its Partner Group NanoXplore Inc.
Marketwired - Wed May 20, 4:00PM CDT
Mason Graphite Inc. ("Mason Graphite" or the "Company" (TSX VENTURE: LLG)(OTCQX: MGPHF) announces that it has entered into two agreements with Group NanoXplore Inc. ("NanoXplore":
LLG.VN: 0.830 (+0.030)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 9

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 12

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 12

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 11

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 16

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 11

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 12

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 14

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Women Through the Gettysburg Salon Experience

Updated Category News Views 116

Reimagining Women's Spaces Through the Gettysburg Salon The Gettysburg Salon is a vibrant platform where women can express themselves creatively and engage in thought-provoking dialogues. This initiative began with three passionate individuals who envisioned a safe space for women to explore their identities, aspirations, and challenges through art and conversation. In a...

Continue Reading
Transforming Off-Road Adventures: Upfit UTV and OMI Innovation

Updated Category News Views 165

Transforming Off-Road Adventures: Upfit UTV and OMI Innovation Upfit UTV, a subsidiary of Fox Factory known for customizing high-performance vehicles, has joined forces with OMI, a leader in electric powertrain engineering. Together, they are redefining off-road adventures with their groundbreaking Fusion-Drive technology. This innovation not only elevates performance but...

Continue Reading
Investor Alert: AstraZeneca Faces Class Action Lawsuit Under SEC Laws

Updated Category News Views 278

Investor Alert Regarding AstraZeneca Securities Class Action Kahn Swick & Foti, LLC, founded by former Attorney General Charles C. Foti, Jr., is highlighting crucial information for investors in AstraZeneca PLC (NASDAQ: AZN) who may have incurred losses exceeding $100,000. The firm reminds those affected that they need to file lead plaintiff applications for their class...

Continue Reading
Important Class Action for GSK plc Investors: Know Your Rights

Updated Category News Views 208

GSK Faces Class Action Lawsuit: Key Information for Investors Levi & Korsinsky, LLP has announced a class action securities lawsuit involving GSK plc, a well-known pharmaceutical company traded on the NYSE under the ticker GSK. This lawsuit is particularly significant for investors who have been adversely affected during a specified period concerning the securities of...

Continue Reading
Denny’s Fundraiser for No Kid Hungry: Making a Difference

Updated Category News Views 435

Denny’s Annual Fundraiser for No Kid Hungry Returns Denny’s is excited to bring back its annual in-restaurant fundraiser to support No Kid Hungry, a national initiative focused on ending childhood hunger in the United States. This campaign will run for a designated period, allowing Denny's restaurants to make a meaningful difference by ensuring that children have...

Continue Reading